Fate Therapeutics (FATE) Leases (2019 - 2025)
Historic Leases for Fate Therapeutics (FATE) over the last 7 years, with Q3 2025 value amounting to $42.4 million.
- Fate Therapeutics' Leases fell 2742.6% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year decrease of 2742.6%. This contributed to the annual value of $46.5 million for FY2024, which is 2459.18% down from last year.
- Per Fate Therapeutics' latest filing, its Leases stood at $42.4 million for Q3 2025, which was down 2742.6% from $43.8 million recorded in Q2 2025.
- Over the past 5 years, Fate Therapeutics' Leases peaked at $70.7 million during Q4 2021, and registered a low of $42.4 million during Q3 2025.
- Its 5-year average for Leases is $60.5 million, with a median of $63.7 million in 2023.
- Per our database at Business Quant, Fate Therapeutics' Leases soared by 542.01% in 2021 and then crashed by 2742.6% in 2025.
- Over the past 5 years, Fate Therapeutics' Leases (Quarter) stood at $70.7 million in 2021, then fell by 6.58% to $66.1 million in 2022, then dropped by 6.65% to $61.7 million in 2023, then dropped by 24.59% to $46.5 million in 2024, then dropped by 8.8% to $42.4 million in 2025.
- Its Leases stands at $42.4 million for Q3 2025, versus $43.8 million for Q2 2025 and $45.2 million for Q1 2025.